Research & Development Center for Cell Therapy

For safe, ensured, and accessible cell therapy

Message from the Director



Safety is the most important requirement for cell therapy which involves cell processing and transplantation by using cells collected from patients. Our center is conducting research and development on formulation of designs for quality testing to ensure safety, and standardization of cell culture method and quality inspection method. In addition, we manufacture cell products in cell processing center (CPC), where cells are cultivated in aseptic condition and also manage and operate manufacturing and quality inspection facilities. In order to reduce the cost of cell therapy, we are also developing a control system that makes manufacturing of cell products more and faster while ensuring safety.

New Release!
This video introduces CPCs of Kobe Eye Center and Kobe Center for Medical Innovation (KCMI) and also demonstrates the messaging platform and applications for cell & gene therapy which is being developed by RDC.


We globally demonstrate business models of medical clusters
that sustainably develop Kobe Biomedical Innovation Cluster.


Summary of RDC Business

Research & Development Center for Cell Therapy (RDC) was established in 2014 to accelerate the social implementation and industrialization of the cell therapy. We create innovation in cell & gene therapy by focusing on research, development and manufacturing, and propose the sustainable development model for Kobe Biomedical Innovation Cluster.

Basic Research/Testing
  • Cell testing service
  • Research for cell manufacturing process
  • Consultation for cell manufacturing
  • Research for cell specification
IND Manufacturing
  • Cell manufacturing service
Commercial Manufacturing
  • Cell manufacturing service




Kobe Eye Center

Brief introduction of our service: RDC is the expert of cell & gene therapy and our activities/services aiming for sustainable development of Kobe Biomedical Innovation Cluster are summarized in this leaflet.


1. KCMI CPC (Japanese only)
New CPC operated by RDC was started running in Kobe Center for Medical Innovation (KCMI) on March 2022. This video taken before opening shows the inside of the CPC.

2. Introduction of Cell Port City (English caption)
Concept of ecosystem “Kobe Cell Port City” proposed by RDC is introduced in this video.

3. Kobe Eye Center CPC (English caption)
This video introduces Kobe Biomedical Innovation Cluster (KBIC) in a tour format including the CPC of Kobe Eye Center, where the commercial product of CAR-T cell therapy is manufactured.

4. Cleanroom suit for cell manufacturing
The optimal clean ware for cell manufacturing co-developed by RDC is introduced in this video in a fashion show format.

(English/Simplified Chinese caption)

(English/Traditional Chinese caption)


Foundation for Biomedical Research and Innovation at Kobe

Research & Development Center for Cell Therapy

1-5-4, Minatojima Minamimachi, Chuo-ku, Kobe

TEL 078-306-0681